Page last updated: 2024-11-01

orphenadrine and Sleep Initiation and Maintenance Disorders

orphenadrine has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gisselmann, A1
Marin, A1
Simon, P1

Other Studies

1 other study available for orphenadrine and Sleep Initiation and Maintenance Disorders

ArticleYear
[Pilot study on the effects of an antiparkinson anticholinergic agent during depressive conditions].
    L'Encephale, 1975, Volume: 1, Issue:4

    Topics: Adult; Aged; Cognition Disorders; Depression; Female; Humans; Male; Middle Aged; Orphenadrine; Sleep

1975